Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TYMS | P04818 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29176374 | 0.87 | CA2 (0.46) | CHRM2ADORA3KCNH2LMNAMAPT | |
| SCHEMBL29176372 | 0.84 | ALOX15 (0.42) | CHRM2ADORA3KCNH2MAPTMEN1 | |
| SCHEMBL29176375 | 0.84 | MAPT (0.43) | CHRM2ADORA3KCNH2LMNAMAPT | |
| SCHEMBL29176373 | 0.80 | NR4A2 (0.50) | LMNASMN1; SMN2POLBCYP1A2HIF1A | |
| Bisoxatin Acetate SCHEMBL364629 | 0.79 | MAPT (0.62) | LMNAMAPTMEN1KMT2AHSD17B10 | |
| Bisoxatin Acetate SCHEMBL31152556 | 0.79 | MAPT (0.62) | LMNAMAPTMEN1KMT2AHSD17B10 | |
| Oxyphenisatine SCHEMBL35387956 | 0.71 | CHRM2 (1.00) | CHRM2ADORA3KCNH2LMNAMAPT | |
| Oxyphenisatine SCHEMBL239513 | 0.71 | CHRM2 (1.00) | CHRM2ADORA3KCNH2LMNAMAPT | |
| SCHEMBL2716060 | 0.69 | CHRM2 (0.93) | CHRM2ADORA3KCNH2LMNAMAPT | |
| SCHEMBL1450379 | 0.68 | BRD4 (0.51) | MAPTHSD17B10ALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220233437-A1 | DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT | BORODY THOMAS J (AU) | 2022-07-28 | — | — | US | claimed |
| EP-3976030-A1 | DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT | Borody, Thomas Julius (AU) | 2022-04-06 | — | — | EP | claimed |
| WO-2020237323-A1 | DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT | BORODY THOMAS J (AU) | 2020-12-03 | — | — | WO | claimed |
| EP-2651415-B1 | GASTRIC AND COLONIC FORMULATIONS AND METHODS FOR MAKING AND USING THEM | RITE PREP PTY LTD (AU) | 2020-10-07 | — | — | EP | claimed |
| US-20190240229-A1 | GASTRIC AND COLONIC FORMULATIONS AND METHODS FOR MAKING AND USING THEM | BAUSCH HEALTH US, LLC | 2019-08-08 | — | — | US | claimed |
| US-10092573-B2 | Gastric and colonic formulations and methods for making and using them | SALIX PHARMACEUTICALS, INC. (US) | 2018-10-09 | — | — | US | claimed |
| CN-104936581-A | Laxative compositions and methods for treating constipation and related gastrointestinal disorders and conditions | SALIX PHARMACEUTICALS INC | 2015-09-23 | — | — | CN | claimed |
| US-20150216806-A1 | LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS | MEDICIS PHARMACEUTICAL CORPORATION | 2015-08-06 | — | — | US | claimed |
| EP-2890367-A1 | LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS | Salix Pharmaceuticals, Inc. (US) | 2015-07-08 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-103338768-A | Stomach and colon formulations and methods of making and using same | BORODY THOMAS J | 2013-10-02 | — | — | CN | claimed |
| WO-2013059881-A1 | ELECTROLYTE PURGATIVES | BORODY THOMAS J | 2013-05-02 | — | — | WO | claimed |
| WO-2012079118-A1 | GASTRIC AND COLONIC FORMULATIONS AND METHODS FOR MAKING AND USING THEM | BORODY THOMAS J (AU) | 2012-06-21 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2008027442-A2 | ABUSE DETERRENT ORAL PHARMACEUTICAL FORMULATIONS OF OPIOID AGONISTS AND METHOD OF USE | THERAQUEST BIOSCIENCES, LLC (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008021394-A2 | PHARMACEUTICAL FORMULATIONS OF CANNABINOIDS AND METHOD OF USE | THERAQUEST BIOSCIENCES, LLC (US) | 2008-02-21 | — | — | WO | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| WO-2007057924-A1 | LAXATIVE COMPOSITION ON THE BASIS OF TRIPHALA | PANACEA BIOTEC LTD (IN) | 2007-05-24 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |